PTO/SBISOEFS (07—09)
`Doc code: RCEX
`Approved for use through 071312012. 0MB 0551—0031
`Doc description: Request for Continued Examination (RCE)
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`REQUEST FOR CONTINUED EXAMINATION(RCE)TRANSMITTAL
`(Submitted Only via EFS-Web)
`
`HPTA—5575
`p°°ket.Number
`2007—02—12
`11/673,836
`Application
`
`Number
`(If applicable)
`
`D-J- Bede”
`Exammer
`F"5t Name‘j M. MIYAMOTO etal
`Name
`Inventor
`
`
`This is a Request for Continued Examination (RCE) under 37 CFR 1.1 14 of the above-identified application.
`Request for Continued Examination (RCE) practice under 37 CFR 1.114 does not apply to any utility or plant application filed prior to June 8,
`1995, or to any design application. The Instruction Sheet for this form is located at WWW.USPTO.GOV
`
`SUBMISSION REQUIRED UNDER 37 CFR1.114
`
`
`Note: If the RCE is proper, any previously filed unentered amendments and amendments enclosed with the RCE will be entered in the order
`in which they were filed unless applicant instructs othenpvise. If applicant does not wish to have any previously filed unentered amendment(s)
`entered, applicant must request non—entry of such amendment(s).
`
`|:| Previously submitted. If a final Office action is outstanding, any amendments filed after the final Office action may be considered as a
`submission even if this box is not checked.
`
`|:| Consider the arguments in the Appeal Brief or Reply Brief previously filed on
`
`|:| Other
`
`E Enclosed
`
`Amendmentheply
`
`|:|
`
`Information Disclosure Statement (IDS)
`
`|:| Affidavit(s)l Declaration(s)
`
`Other
`
`Petition for Extension of Time
`
`MISCELLANEOUS
`
`El Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for a period of months
`(Period of suspension shall not exceed 3 months; Fee under 37 CFR 1.17(i) required)
`
`|:| Other
`
`
`
`|:| Applicant Signature
`
`The RCE fee under 37 CFR 1.17(e) is required by 37 CFR 1.114 when the RCE is filed.
`The Director is hereby authorized to charge any underpayment of fees, or credit any overpayments, to
`Deposit Account No
`501417
`
`FEES
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
`
`Patent Practitioner Signature
`
`EFS - Web 2.1.15
`
`